The characterization of anaplastic lymphoma kinase (ALK) gene and their role in the development and progression of ALK positive cancer has transformed the cancer therapeutics market. The extensive research activities by the researchers have led to the development of novel anaplastic lymphoma kinase inhibitors which belongs to the class of tyrosine receptor kinase and are used in the management of cancer.
The global Anaplastic Lymphoma Kinase ALK Inhibitor market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on Anaplastic Lymphoma Kinase ALK Inhibitor volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Anaplastic Lymphoma Kinase ALK Inhibitor market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Anaplastic Lymphoma Kinase ALK Inhibitor Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
First Generation ALK Inhibitor
Second Generation ALK Inhibitor
Third Generation ALK Inhibitor
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Astellas Pharma
AstraZeneca
Betta Pharmaceuticals
GlaxoSmithKline
Merck
Novartis
Pfizer
Roche
Takeda Pharmaceuticals
Turning Point Therapeutics
The global Anaplastic Lymphoma Kinase ALK Inhibitor market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on Anaplastic Lymphoma Kinase ALK Inhibitor volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Anaplastic Lymphoma Kinase ALK Inhibitor market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Anaplastic Lymphoma Kinase ALK Inhibitor Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
First Generation ALK Inhibitor
Second Generation ALK Inhibitor
Third Generation ALK Inhibitor
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Astellas Pharma
AstraZeneca
Betta Pharmaceuticals
GlaxoSmithKline
Merck
Novartis
Pfizer
Roche
Takeda Pharmaceuticals
Turning Point Therapeutics
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.